Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 95.10
-1.10 (-1.14%)
Sep 30, 2026, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 6.43 billion as of September 29, 2026. Its market cap has decreased by -54.94% in one year.
Market Cap
6.43B
Enterprise Value
4.14B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
95.10
ChartMarket Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 6.43B, an increase of 150.53%. That is a compound annual growth rate of 16.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 6.43B | -68.36% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grape King Bio | 12.89B |
| Foresee Pharmaceuticals | 12.63B |
| Standard Chemical & Pharmaceutical | 10.04B |
| SCI Pharmtech | 6.78B |
| Yoda Pharmaceuticals | 6.00B |
| Orient Pharma | 5.83B |
| Formosa Laboratories | 5.78B |
| LIWANLI Innovation | 4.71B |